Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Bristol-Myers scoops Inhibitex for $2.5bn

Jan 09 2012

Related Companies

Pharmasset, Inc.

Novartis AG

Inhibitex, Inc.

Gilead Sciences, Inc.

Bristol Myers Squibb Company

Achillion Pharmaceuticals, Inc.

Abbott

More from Archive

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window